Deciphera Pharmaceuticals
The Scientist III will independently design, execute, and interpret biochemical and cellular assays to support drug discovery, collaborating with cross‑functional teams and managing CRO activities. The role involves assay development, data analysis, documentation, and mentoring junior scientists within a fast‑paced biotech environment.
Headquarters
Waltham, Massachusetts, United States
Company Size
201-500 employees
Founded
2003
Deciphera Pharmaceuticals, now a member of ONO Pharma, is a biopharmaceutical company dedicated to discovering, developing, and commercializing switch-control kinase inhibitors and other targeted therapies to improve outcomes for people with cancer. The company's portfolio includes approved medicines QINLOCK (ripretinib) for advanced gastrointestinal stromal tumor and ROMVIMZA (vimseltinib), as well as a broad pipeline of clinical-stage candidates such as tirabrutinib and sapablursen. Driven by a patient-inspired mission to defeat cancer, Deciphera focuses on addressing key mechanisms of tumor and drug resistance through its proprietary discovery platform.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Deciphera Pharmaceuticals.
22% below the average for this role
Scientist II
WuXi AppTec
Senior Assay and Automation Scientist
AstraZeneca
Director, Discovery Biology
Neurocrine Biosciences
Senior Scientist
Gilead Sciences
Research Specialist / Sr Scientist, Assay Sciences, Discovery Pharmacology
Altos Labs
Principal Scientist, Assay Profiling - Lead Identification and Optimization (80-100%*)
Novartis